Request Deal Involvement
Eli Lilly to acquire Disarm Therapeutics for $135m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Ten Bridge Communications
financial advisors
Aquilo Partners
legal advisors
WilmerHale
or
Principals
bidder
ELI LILLY AND COMPANY
target
DISARM THERAPEUTICS
vendor
ATLAS VENTURE LP
vendor
BIOGENERATOR
vendor
LIGHTSTONE VENTURES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite